Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excretion Balance and PK of Batefenterol in Healthy Men
NCT02663089Phase 1Completed
- Sponsor
- Theravance Biopharma, Inc.
- Start
- Feb 2016
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of batefenterol in chronic obstructive pulmonary disease (COPD), sponsored by Theravance Biopharma, Inc. Primary endpoints: Area Under the Curve (AUC) of total drug-related material, Maximum Observed Plasma Concentration and 5 more. Started Feb 2016; status: completed.
02
Drugs
batefenterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02663089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02663089.